Frequency-agile lasers for photonic sensing
FORTE aims to develop a scalable, high-performance, photonic integrated circuit-based laser technology for fiber sensing and FMCW LiDAR, enhancing manufacturing and reducing costs.
Projectdetails
Introduction
Lasers are a ubiquitous technology in optical communication, sensors, LiDAR, or emerging quantum science and technology. Yet, the principles by which lasers are manufactured have remarkably not changed since the invention of the laser: they are assembled by hand, using bulk components or optical fibers.
Current Limitations
While integrated lasers based on silicon photonics exist, they do not challenge such high-performance legacy laser systems. FORTE will change this notion. Building on a recent breakthrough in the field of low-loss integrated photonics, it is today possible to create lasers that are low cost, wafer-scale manufacturable, and have better performance than the fiber laser – the workhorse of fiber sensing and the gold standard in coherence.
Project Ambition
The overarching ambition of this EIC transition project is to:
- Develop a prototype and mature photonic integrated circuit-based frequency-agile ultra-low noise laser technology.
- Apply it to the domain of fiber sensing and FMCW LiDAR.
- Develop a scalable manufacturing process.
Unique Selling Points
The unique selling points (USP) of the platform are:
- Based on photonic integrated circuit technology that is scalable, flexible, and reconfigurable.
- Extremely high performance in terms of optical coherence and frequency agility.
Technology Overview
The technology is based on a patented approach that combines:
- Ultra-low loss photonic integrated circuits based on silicon nitride.
- MEMS technology, as used in wireless technology.
This approach addresses the need for low-noise laser sources in multiple domains of photonic sensing, including:
- Distributed fiber optic sensing (DFOS).
- Coherent laser ranging (FMCW LiDAR).
Consortium and Commercialization
The consortium includes companies in fiber sensing, LiDAR, as well as in the development of industrial manufacturing tools. The results will be commercialized by the involvement of SMEs in fiber sensing and a dedicated startup to bring hybrid integrated frequency-agile low noise lasers to the market.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.966.218 |
Totale projectbegroting | € 1.966.218 |
Tijdlijn
Startdatum | 1-10-2023 |
Einddatum | 31-3-2026 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- THALESpenvoerder
- ARAGON PHOTONICS LABS SL
- FICONTEC SERVICE GMBH
- ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
- DEEPLIGHT SA
Land(en)
Vergelijkbare projecten binnen EIC Transition
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Targeting cardiac fibrosis with next generation RNA therapeuticsFIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness. | EIC Transition | € 2.499.482 | 2022 | Details |
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationSThe NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring. | EIC Transition | € 2.497.750 | 2022 | Details |
Predictive REagent-Antibody Replacement Technology stage 2-TranslationPRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment. | EIC Transition | € 800.000 | 2022 | Details |
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stageDeveloping a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships. | EIC Transition | € 2.499.810 | 2022 | Details |
Targeting cardiac fibrosis with next generation RNA therapeutics
FIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness.
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationS
The NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring.
Predictive REagent-Antibody Replacement Technology stage 2-Translation
PRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment.
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stage
Developing a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Integrated photonic circuit fabrication by femtosecond laser writing for quantum informationThe PhotonFAB project aims to enhance the production of integrated photonic devices for quantum applications using femtosecond laser writing, targeting commercial viability and market expansion. | ERC POC | € 150.000 | 2022 | Details |
Photonic Laser Integration for Metrology and Quantum SystemsLASIQ aims to develop a compact on-chip titanium-sapphire mode-locked laser for low-noise optical frequency combs, enhancing precision spectroscopy and enabling advanced metrology applications. | ERC STG | € 1.490.625 | 2023 | Details |
Pre-commercialization of new generation Atomic-layer-deposited Lasers for future green high-performance data centersThis project aims to develop a low-cost, scalable silicon photonics fabrication technology to enhance energy efficiency in hyperscale data centers while meeting increasing bandwidth demands. | ERC POC | € 150.000 | 2023 | Details |
Frequency-agile integrated photonic light sources across the visible and near-infrared spectrumAgiLight aims to develop a new class of integrated lasers with wideband tunability and high precision for diverse applications, leveraging advanced photonic integration and 3D printing technology. | EIC Pathfinder | € 2.786.477 | 2024 | Details |
Integrated photonic circuit fabrication by femtosecond laser writing for quantum information
The PhotonFAB project aims to enhance the production of integrated photonic devices for quantum applications using femtosecond laser writing, targeting commercial viability and market expansion.
Photonic Laser Integration for Metrology and Quantum Systems
LASIQ aims to develop a compact on-chip titanium-sapphire mode-locked laser for low-noise optical frequency combs, enhancing precision spectroscopy and enabling advanced metrology applications.
Pre-commercialization of new generation Atomic-layer-deposited Lasers for future green high-performance data centers
This project aims to develop a low-cost, scalable silicon photonics fabrication technology to enhance energy efficiency in hyperscale data centers while meeting increasing bandwidth demands.
Frequency-agile integrated photonic light sources across the visible and near-infrared spectrum
AgiLight aims to develop a new class of integrated lasers with wideband tunability and high precision for diverse applications, leveraging advanced photonic integration and 3D printing technology.